Vaneck Vectors Pharmaceutical etf shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $132M | 1.4M | 91.48 |
| 2024-03-31 | $122M | 1.3M | 90.70 |
| 2023-12-31 | $114M | 1.4M | 81.37 |
| 2023-09-30 | $132M | 1.6M | 79.86 |
| 2023-06-30 | $88M | 1.1M | 78.77 |
| 2023-03-31 | $124M | 1.6M | 77.63 |
| 2022-12-31 | $144M | 1.9M | 77.74 |
| 2022-06-30 | $28M | 360k | 76.84 |
| 2022-03-31 | $12M | 147k | 79.76 |
| 2021-12-31 | $11M | 147k | 76.96 |
| 2021-09-30 | $11M | 147k | 72.82 |
| 2021-03-31 | $100M | 1.4M | 69.02 |
| 2020-12-31 | $15M | 220k | 66.47 |
| 2020-09-30 | $14M | 220k | 62.17 |
| 2020-06-30 | $17M | 265k | 62.26 |
| 2019-12-31 | $22M | 344k | 64.18 |
| 2019-09-30 | $21M | 364k | 56.99 |
| 2019-06-30 | $9.6M | 164k | 58.67 |
| 2019-03-31 | $27M | 450k | 60.72 |
| 2018-12-31 | $38M | 700k | 54.79 |
| 2018-09-30 | $52M | 800k | 64.35 |
| 2018-06-30 | $48M | 809k | 59.00 |
| 2018-03-31 | $37M | 651k | 56.83 |
| 2017-12-31 | $15M | 250k | 59.31 |
| 2017-09-30 | $20M | 351k | 57.76 |
| 2017-06-30 | $21M | 350k | 59.06 |
| 2017-03-31 | $41M | 750k | 55.14 |
| 2016-12-31 | $29M | 550k | 52.51 |
| 2016-09-30 | $103M | 1.8M | 57.46 |
| 2016-06-30 | $89M | 1.5M | 58.62 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf